TLX 18 Mar 2026, 8:24 AM

Appendix 3Y Change in Director Interests - C Behrenbruch

TELIX Pharmaceuticals Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in